Abbott Laboratories (ABT) Strikes Deals To Purchase 2 Device CompaniesVW Staff
Abbott Laboratories (NYSE:ABT) announced it has entered into an agreement to purchase two companies to add to its Medical Device portfolio: IDEV Technologies, a peripheral play ($310 million) and OptiMedica, an ophthalmic device company ($250 million+$150 million milestone based payments).
Deal impact: IDEV Technologies & OptiMedica
Management expects to close both deals before the end of the year and have a neutral impact in 2013-2014 . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.